Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Roma La Sapienza University College London Hospitals |
---|---|
Information provided by: | University of Roma La Sapienza |
ClinicalTrials.gov Identifier: | NCT00610350 |
The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revascularization under cardiopulmonary bypass.
Condition | Intervention | Phase |
---|---|---|
Myocardial Protection |
Drug: levosimendan Drug: Placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Levosimendan Pre-Treatment in Patients Undergoing Coronary Artery Bypass Graft Surgery: a Double-Blind, Single Center, Prospective, Randomized, Placebo-Controlled Trial |
Enrollment: | 100 |
Study Start Date: | January 2005 |
Study Completion Date: | February 2007 |
Primary Completion Date: | February 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
L: Experimental |
Drug: levosimendan
24 μg/kg administered as a slow i.v. 50 ml bolus through the central venous port of a pulmonary artery catheter over the 10 minutes before initiation of CPB
|
P: Experimental |
Drug: Placebo
an identical-appearing placebo prepared and labelled by the pharmacy was administered as a slow i.v. 50 ml bolus through the central venous port of a pulmonary artery catheter over the 10 minutes before initiation of CPB
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Italy | |
University of Rome "Sapienza" | |
Rome, Italy, 00155 |
Principal Investigator: | Vincenzo De Santis, M.D. | University of Rome "Sapienza" |
Responsible Party: | University of Rome "Sapienza" ( Vincenzo De Santis ) |
Study ID Numbers: | LV 2003, LV-2003-01 |
Study First Received: | January 24, 2008 |
Last Updated: | February 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00610350 |
Health Authority: | Italy: Ethics Committee |
Levosimendan pre-conditioning cardiac surgery myocardial function |
contractility heart ischaemia |
Ischemia Simendan |
Vasodilator Agents Phosphodiesterase Inhibitors Molecular Mechanisms of Pharmacological Action Cardiotonic Agents Therapeutic Uses Physiological Effects of Drugs |
Enzyme Inhibitors Cardiovascular Agents Anti-Arrhythmia Agents Protective Agents Pharmacologic Actions |